| Systematic (IUPAC) name | |
|---|---|
| 1-(3-((E)-3-phenylprop-2-enyl)- 3,8-diazabicyclo [3.2.1]octan-8-yl) propan-1-one | |
| Clinical data | |
| Pregnancy cat. | ? |
| Legal status | Legal |
| Identifiers | |
| CAS number | 448-34-0 |
| ATC code | None |
| PubChem | CID 6433185 |
| ChemSpider | 16736583 |
| UNII | D20F1K1BYP |
| Chemical data | |
| Formula | C18H24N2O |
| Mol. mass | 284.396 |
| SMILES | eMolecules & PubChem |
|
|
| Physical data | |
| Melt. point | 170–175 °C (338–347 °F) |
| |
|
Azaprocin is a drug which is an opioid analgesic with approximately 10x the potency of morphine, and a fast onset and short duration of action.[1][2][3] It was discovered in 1963, but has never been marketed.
The derivative substituted on the phenyl ring with a p-nitro group is more potent than the parent compound, around 25x the potency of morphine.[4] The ring-opened 2,6-dimethylpiperazine analogues are also active,[5] and a large family of opioid analgesic compounds derived from this parent structure have been developed over the last 40 years.[6][7][8][9][10][11][12][13][14][15]
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)